Amgen Enbrel Clears FDA For Psoriasis Supplemental Indication; Detailing Begins Immediately
This article was originally published in The Pink Sheet Daily
Executive Summary
The company calls on 3,500 dermatologists for its psoriatic arthritis indication; Amgen hopes to increase promotion to 9,000 dermatolgists.